Skip to search formSkip to main contentSkip to account menu

LY 465608

Known as: LY-465608, LY 465,608, LY465608 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Organic Chemicals

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Scaffold-Based Pan-Agonist Design for the PPARα, PPARβ and PPARγ Receptors
As important members of nuclear receptor superfamily, Peroxisome proliferator-activated receptors (PPAR) play essential roles in… 
2007
2007
Underlying mechanisms of pharmacology and toxicity of a novel PPAR agonist revealed using rodent and canine hepatocytes.
Marked species-specific responses to agonists of the peroxisome proliferator-activated alpha receptor (PPAR alpha) have been… 
Highly Cited
2002
Highly Cited
2002
A tailored therapy for the metabolic syndrome: the dual peroxisome proliferator-activated receptor-alpha/gamma agonist LY465608 ameliorates insulin resistance and diabetic hyperglycemia while…
A novel nonthiazolidinedione dual peroxisome proliferator- activated receptor (PPAR)-alpha/gamma agonist, LY465608, was designed… 
2002
2002
Peroxisome proliferator-activated receptor α,γ coagonist LY465608 inhibits macrophage activation and atherosclerosis in apolipoprotein E knockout mice
The apolipoprotein F (apoF) knockout mouse has provided an approach to the investigation of the effect of both cellular and… 
2002
2002
Peroxisome proliferator-activated receptor alpha,gamma coagonist LY465608 inhibits macrophage activation and atherosclerosis in apolipoprotein E knockout mice.
The apolipoprotein E (apoE) knockout mouse has provided an approach to the investigation of the effect of both cellular and… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)